Shanghai Pharmaceuticals Holding Co., Ltd
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 601607.SS | 600511.SS | 600998.SS | X2S.F | 600056.SS | 002589.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 62.34B | 21.87B | 26.47B | 5.94B | 13.54B | 4.33B |
| P/E (TTM) | 12.1 | 11.1 | 13.8 | 6.8 | 43.1 | 288.0 |
| Forward P/E | 10.3 | 10.3 | 12.1 | — | 5.2 | — |
| Price/book | 0.8 | 1.1 | 0.9 | 0.5 | 1.1 | 0.8 |
| Dividend yield | 2.67% | 2.77% | 3.75% | 4.63% | 1.05% | 0.07% |
| 1-year change | −5.60% | −2.40% | +4.91% | −12.64% | −20.02% | −3.73% |
| Today | −0.30% | +0.28% | −1.69% | −0.88% | +0.22% | +1.41% |
The closest companies by business and industry (Medical Distribution). Prices may be delayed up to 15 min.
Latest news
All 601607.SS news ›Shanghai Pharmaceuticals Holding Co., Ltd. Enters Property Leasing Framework Agreement with Shanghai Pharmaceutical Co., Ltd
Published on 10/29/2026 at 05:50 am EDT Shanghai Pharmaceuticals Holding Co. Ltd. entered into the Property Leasing Framework Agreement with Shanghai Pharmaceutical (Group) Co. Ltd. in respect of the property leasing service provided by…
Shanghai Pharmaceuticals Holding Co., Ltd: Total Return chart (Dividends reinvested) - Shanghai S.E. stock market
See the history of Shanghai Pharmaceuticals Holding Co., Ltd, with dividends reinvested. (Total Return chart) 601607 Stock market Total Return chart Shanghai Pharmaceuticals Holding Co., Ltd Past dividends on Shanghai Pharmaceuticals…
Shanghai Pharmaceuticals Gets Registration Certificate for Paclitaxel Injection
Shanghai Pharmaceuticals obtained a drug registration certificate from China's National Medical Products Administration for paclitaxel injection, according to a Tuesday disclosure on the Shanghai... Shanghai Pharmaceuticals Holding Co.,…
Application Cases of Wastewater Discharge Outlets in Shanghai's Pharmaceutical Industry
Pudong Shanghai China October 13 2026 A biopharmaceutical company based in Shanghai engaged in technical research within the field of biological products as well as the production and processing of laboratory reagents intermediates…
China's Shanghai Pharmaceuticals wins production approval for clevidipine injectable emulsion; R&D spend hits 52.2 million yuan
Shanghai Pharmaceuticals' subsidiary SPH No.1 Biochemical & Pharmaceutical has received a Drug Registration Certificate from China's National Medical Products Administration for clevidipine injectable emulsion, clearing the drug for…
Shanghai Pharmaceuticals Holding Co., Ltd Stock (601607) - Quote Shanghai S.E.
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company mainly engaged in pharmaceutical distribution business. The Company mainly operates four business segments. The Industrial segment is mainly engaged in the research and…
Shanghai Pharmaceuticals Subsidiary Gets China Approval for Antibiotic
Shanghai Pharmaceuticals subsidiary Shanghai Hefeng Pharmaceutical obtained approval from China's National Medical Products Administration for its lincomycin hydrochloride injection, according to... Shanghai Pharmaceuticals Holding Co.,…
Shanghai Pharmaceuticals Declares Interim Dividend
Shanghai Pharmaceuticals will pay out a cash dividend of 0.10 yuan per share for the first half to holders of its Shanghai-listed A shares, according to a Friday bourse filing in Shanghai. The... Shanghai Pharmaceuticals Holding Co., Ltd…
Shanghai Pharmaceuticals' Unit Gets Registration Certificates for Clevidipine Injectable Emulsion
Shanghai Pharmaceuticals' unit, Shanghai Shangyao No. 1 Biochemical & Pharmaceutical, received drug registration certificates from China's National Medical Products Administration for clevidipine... Shanghai Pharmaceuticals Holding Co.,…
Shanghai Pharmaceuticals Gets China Clinical Trial Nod for Hypertension Inhalation Powder
Shanghai Pharmaceuticals received clinical trial approval from China's National Medical Products Administration for its Treprostinil Diolamine inhalation powder, according to a Thursday filing... Shanghai Pharmaceuticals Holding Co., Ltd…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com11
- finance.biggo.com1
- openpr.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.